Envisia Therapeutics Garners $10,117,521 Series A Funding

  • Feed Type
  • Date
  • Company Name
    Envisia Therapeutics
  • Mailing Address
    P.O. Box 110065 Research Triangle Park, NC 27709 USA
  • Company Description
    Envisia encourages applications from highly motivated individuals who excel in their field of expertise and enjoy a fast-paced, challenging work environment.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series A
  • Proceeds Purposes
    Total amount sold includes the value of cancelled indebtedness formerly held by certain purchasers in the aggregate principal amount of $4,944,000. Proceeds purposes were not disclosed. 9 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
  • M&A Terms
  • Venture Investor

Trending on Xconomy